FDA Development of new stereoisomeric drugs

Title:
FDA Development of new stereoisomeric drugs

https://www.gmp-compliance.org/files/guidemgr/cder_guidance_stereo.pdf

Origin/Publisher:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/cder/guidance

Document Type:
FDA Guidance for Industry
Content:
Development of new stereoisomeric drugs

Go back